HomeClinical TopicsFDA allows marketing of cooling cap for chemotherapy

FDA allows marketing of cooling cap for chemotherapy

On Dec. 8, the U.S. Food and Drug Administration (FDA) cleared the Dignitana DigniCap Cooling System for marketing. The system reduces the frequency and severity of alopecia during chemotherapy in breast cancer patients. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content